Description

Humana’s CenterWell Expansion Could Reshape Its Long-Term Care Delivery Model!

Humana Incorporated reported first-quarter results that aligned with its internal expectations, reflecting a stable start to 2026 amid ongoing strategic initiatives. Management emphasized adherence to their previously disclosed commitment of returning to a sustainable Medicare Advantage (MA) margin of at least 3% by 2028, with measurable progress expected in 2027. The company continues to manage growth dynamics carefully, maintaining a focus on membership retention and benefit adjustments to address the persistent gap between medical cost trends and program funding. Membership growth remains on track, supported by both new and returning members performing in line with guidance across key metrics such as risk scores, hospital admissions, pharmacy claims, and medical claims. Early efforts in the 2029 Star ratings cycle show promising engagement and improved outcomes, with the company approximately 5% ahead in gap closure metrics compared to the prior year.